首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1490109

急性叢集性癲癇市場：依藥物類型、給藥途徑、通路及地區分類

Acute Repetitive Seizures Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年05月14日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2024 年全球急性叢集性癲癇發作市場規模為 31 億美元，預計 2031 年將達到 71.2 億美元，2024 年至 2031 年年複合成長率為 12.6%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	31億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年年複合成長率：	12.60%	2031年價值預測	71.2億美元

圖：2024 年按地區分類的急性叢集性癲癇市場佔有率(%)

急性叢集性癲癇發作 (ARS) 的特徵是 24 小時內兩次或兩次以上無端癲癇發作，且兩次癲癇發作之間意識沒有恢復。急性叢集性癲癇發作顯著增加癲癇患者的疾病負擔。導致全球 ARS 人數增加的因素包括更容易癲癇發作的人口老化，以及中風、腦損傷和神經感染疾病引起的癲癇盛行率增加。然而，ARS 治療方案的進步，例如新一代抗驚厥藥物和醫院急診護理專用通訊協定，預計將在不久的將來幫助患者並推動市場成長。

市場動態：

全球急性叢集性癲癇市場的成長是由全球癲癇盛行率不斷上升所推動的。據估計，全世界有 5000 萬人患有癲癇症。此外，不斷增加的老年人口更容易患神經病變、中風和導致癲癇發作的腦損傷，這推動了預測期內對急性叢集性癲癇治療的需求。然而，低收入地區高昂的緊急醫療費用和未滿足的醫療需求可能會阻礙市場成長。廉價非專利藥抗驚厥藥物的開拓為市場成長提供了機會。旨在提高對及時識別和治療 ARS 的認知的舉措可以降低死亡率和殘疾率。

本研究的主要特點

本報告對全球急性叢集性癲癇市場進行了詳細分析，並介紹了以 2023 年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球急性叢集性癲癇市場的主要企業進行了分析。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球急性叢集性癲癇市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
透過用於分析全球急性叢集性癲癇市場的各種策略矩陣，將促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 3.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	12.60%	2031 Value Projection:	US$ 7.12 Bn

Acute repetitive seizures (ARS) are characterized by two or more unprovoked seizures occurring within a 24-hour period without restoration of consciousness between the seizures. Acute repetitive seizures contributes significantly to the disease burden among epileptic patients. Factors contributing to increase in ARS cases globally includes growing geriatric population prone to seizures and increasing prevalence of epilepsies arising from strokes, brain injuries, and neuroinfectious. However, advancements in ARS treatment options such as newer generation anticonvulsants and dedicated emergency treatment protocols in hospitals are expected to aid patients and drive the market growth in the near future.

Market Dynamics:

Global acute repetitive seizures market growth is p driven by increasing incidence of epilepsy worldwide. It is estimated that 50 million people suffer from epilepsy globally. Furthermore, rising geriatric population susceptible to neurological disorders, strokes, and brain injuries leading to seizures boosts demand for acute repetitive seizures treatment over the forecast period. However, high costs of emergency care and unmet medical needs in low-income regions can hamper the market growth. Development of inexpensive generic anticonvulsants provides opportunities for the market growth. Initiatives aimed at raising awareness about timely identification and treatment of ARS can reduce mortality and disability rates.

Key Features of the Study:

This report provides an in-depth analysis of the global acute repetitive seizures market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global acute repetitive seizures market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Neurelis, Inc., Bausch Health Companies Inc., Alexza Pharmaceuticals, Inc., VERITON PHARMA, UCB S.A., Takeda Pharmaceutical Company Limited, Pfizer Inc., Sanofi, GSK plc, Eisai Co., Ltd., H. Lundbeck A/S, Cognizance Biomarkers, LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global acute repetitive seizures market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute repetitive seizures market.

Detailed Segmentation-

By Drug Type:
- Benzodiazepines
- Antiepileptic drugs
- Barbiturates
- Others (Late Phase Drugs, etc.)
By Route of Administration:
- Oral
- Injectable
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Neurelis, Inc.
- Bausch Health Companies Inc.
- Alexza Pharmaceuticals, Inc.
- VERITON PHARMA
- UCB S.A.
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Sanofi
- GSK plc
- Eisai Co., Ltd.
- Lundbeck A/S
- Cognizance Biomarkers, LLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Acute Repetitive Seizures Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Acute Repetitive Seizures Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Benzodiazepines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antiepileptic drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Barbiturates
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Late Phase Drugs, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Acute Repetitive Seizures Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Acute Repetitive Seizures Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Acute Repetitive Seizures Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Neurelis, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bausch Health Companies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Alexza Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- VERITON PHARMA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- UCB S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eisai Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- H. Lundbeck A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cognizance Biomarkers, LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

急性復發性癲癇市場規模、佔有率、趨勢分析報告：產品、地區、細分市場預測，2025-2030 年

急性復發性癲癇市場：依產品、最終用途分類 - 2025-2030 年全球預測

急性重複性癲癇發作市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

到 2030 年急性癲癇群聚市場預測：按產品類型、給藥途徑、分銷管道、最終用戶和地區進行的全球分析

急性復發性癲癇市場、佔有率、規模、趨勢、產業分析報告：依產品、最終用途、地區和細分市場預測，2024-2032 年

全球急性集群性癲癇市場 - 全球產業分析、規模、份額、成長、趨勢、區域展望、預測（2023-2030）

FAQ

急性叢集性癲癇市場：依藥物類型、給藥途徑、通路及地區分類